Loading markets…

Novavax, Inc. (NVAX) forecast

Novavax, Inc. (NVAX) forecast: price $9.93, trailing P/E -7.52, forward P/E 378.37. How to read the street's path.

$9.93Price
$1.64BMarket cap
-7.52P/E ?
378.37Forward P/E ?
0.00%Dividend yield ?

The live NVAX price is $9.93. Trailing P/E is -7.52 and forward P/E is 378.37. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the NVAX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full NVAX quote · Dividends · Price prediction · Academy

Questions

What is NVAX's forward P/E?

The latest forward P/E on Stocklytics is 378.37, against a trailing P/E of -7.52 and a price of $9.93.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.